Where: Building 20, Auditorium
Credit: 1
Description
Lecture by Hosam Mamoon A. Zowawi, Honorary Fellow, UQ Centre for Clinical Research at The University of Queensland, a 2014 Rolex Awards for Enterprise young laureate, and a Next Generation Leader by TIME Magazine.
ABOUT THIS LECTURE
Infections due to multidrug resistance bacteria (aka, superbugs) are a leading cause of morbidity and mortality worldwide. Antimicrobial resistance (AMR) is increasingly being highlighted as an urgent threat to public and animal health. This issue is forecasting a near future with untreatable infections.
Tackling this global challenge requires urgent efforts to control the spread and emergence of superbugs successfully. This talk will give an overview of AMR with a focus on the Middle East and will highlight the challenges that may contribute to their spread. That will subsequently lead to discuss the opportunities and efforts to tackle superbugs and the resulted "invisible pandemic".
Hosam M. Zowawi is a Rolex Awards for Enterprise Laureate for pioneering efforts to expand knowledge and improve human life.
ABOUT THE ROLEX AWARDS FOR ENTERPRISE
For more than four decades, through the Rolex Awards for Enterprise, Rolex has supported exceptional individuals who have the courage and conviction to take on major challenges; men and women who have a spirit of enterprise, initiating extraordinary projects that make the world a better place. Find out more.
The Academic Lectures are a series of lectures featuring a range of in-Kingdom and international entrepreneurs, academics and distinguished guest speakers.
Check out this event’s photo gallery!
Watch this lecture!
Watch the podcast interview with Hosam M. Zowawi!
Hosam Zowawi
Hosam Mamoon Zowawi, Ph.D., is a clinical microbiologist and infectious diseases scientist interested in antibiotic-resistant bacteria. Dr. Zowawi and his collaborators at the Gulf Cooperation Council (GCC) States have founded the first region-wide surveillance program to monitor the spread and emergence of antimicrobial resistance in the Gulf States. As a clinical microbiologist, he recognizes the need to develop more rapid diagnostic tools to aid the rapid implementation of targeted medical management. Hence, he is also focusing on developing innovative tests to identify infectious diseases rapidly. He has joined cave expeditions with the belief that it will provide valuable understanding about the evolution of microbes and antimicrobial resistance. He has received multiple awards and recognitions, such as the Rolex Awards for Enterprise, NHMRC Peter Doherty Fellowship, or Next Generation Leader by TIME Magazine, among others.
No resources found.
No links found.
